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Introduction 
 
In this policy briefing, we illustrate the development and potential of tools developed from 
commissioned public health research project where empirical ethics was combined with human rights 
to elucidate a critical framework for conducting and evaluating Randomised Controlled Trials (RCTs) in 
public health and disability.1 Public health research often struggles with conceptualising the different 
consequences of having lifelong, acquired or fluctuating conditions, as well as integrating how social 
disadvantage, gender, ethnicity, sexual orientation and life-course mediate those everyday experiences, 
including experiences of health. However, the potential impact of public health interventions on 
disadvantaged populations, in terms of ensuring health and flourishing with disability is considerable, 
hence the need for more inclusive and better informed research. Thus, England’s major health research 
funding agency, the National Institute for Health Research - Public Health Research (NIHR-PHR), issued 
a call for a review of the implications of models and theories of disability for public health research. Our 
team secured the contract for this scoping review, with inputs from panels of politically and socially 
active disabled people and their organisations, as well as from public health professionals.2 
 
In the United Kingdom (UK), evaluative research has focused on the retrospective effects of policy on 
health and impact on health inequalities.3,4 This research, by contrast, concentrated on how the 
evidence for public health and disability policy was being constructed. RCTs of interventions are viewed 
as the gold standard of scientific research and evidence informed medicine and are increasingly 
important in terms of influencing policy decisions. Despite this, there is limited critical theoretical and 
practical research about how exactly disability and people with disabilities are being integrated in RCTs, 
their designs and the establishment of research priorities by researchers and commissioners. Previous 
studies have mostly recorded exclusions of population groups most affected by health inequalities, such 
as people with intellectual disabilities.5,6,7 While public health interventions are often presumed to apply 
to an entire population, exclusions illustrate this is not the case. 
 
Our study began with a scoping of disability theories and models of disability. We identified that human 
rights models1 had the most in common with ecological models of public health8 and public health 
policy focusing on the social determinants of health.9 We found that human rights models focused on 
issues of equity and individual rights within societies, while also advocating legislative, social and 
structural policy changes for greater environmental inclusion. We then undertook a systematic review 
of public health intervention research found in the Cochrane Library of Systematic Reviews. We 
examined 30 research reviews of generic public health interventions and 30 reviews of specific public 
health interventions focusing on persons with disabilities. We found that disability mainstreaming was 
not a part of many generic RCTs and much of the specific evaluations focusing  on disability were not 
disability sensitive or inclusive. Of further significance were the ethical and empirical gaps within how 
public health RCTs were being constructed and evaluated. We found several lacunas, from the 
exclusion of people and children with various forms of disabilities, inappropriate use of outcome 
measures, to the total lack of evaluation of disability theory and integration into public health.1 We thus 
wanted to find a way in which human rights paradigms could be used to build an ethical bridge to 
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improve the inclusivity of public health research, making it relevant to disability experiences across the 
life-course and more empirically robust. 
Public Health, Disability and RCTs 
 
In recent years there has been a renewed interest in reconceptualising the relationship between public 
health and disability 10, 11, 12 In industrialised countries like the UK, this has been due to technological 
and medical innovations now enabling people with complex disabilities, diseases and conditions to live 
longer, the biological and socio-cultural discovery of new forms of disability that can be identified 
early, and an aging population acquiring disabilities. This has required a public health shift from 
traditional focus on prevention of disability or its conceptualisation as minority issue, to the promotion 
of healthy lives and quality of life across the life course.10 Such a shift also includes an understanding of 
social participation and inclusion of persons with disabilities, as well as ensuring an identification of 
environmental barriers to health.13,14 
 
At the same time, the public health and disability context linked to health inequalities and social 
gradients linked to ill-health are still deeply entrenched, with differences in mortality and morbidity 
between the poorer North and richer South of England.3 Countries, like England, have also been 
impacted by the political and social effects of the 2008-2009 economic crisis. The government policy 
responses in terms of neoliberal austerity measures and social welfare cuts have led to increases of ill-
health.4 This has meant that health inequalities affecting persons with disabilities have been increasing, 
affecting people with intellectual disabilities and mental health conditions in particular. For instance, 
Heslop et al.,15 in their confidential inquiry into premature deaths of people with learning difficulties in 
the UK, found that men with intellectual disabilities die 13 years earlier and women 20 years earlier 
than the general population. 
 
The relationship of public health and disability, despite obvious synergies in terms of a paradigm shift 
towards ensuring diversity across the life-course and a focus on health inequalities10,2 has always been 
ethically fraught. The historical association with eugenics in terms of disability prevention, surveillance 
and incarceration, as well as the complex relationship between the new genetics - and its association 
with ‘soft eugenics’ - and the rights of disabled people are often mentioned.16, 17,18 However, people 
with disabilities voice more complex and nuanced points about involvement in research, especially 
noting that they had a ‘right’ to set agendas and be involved if it was going to lead to medical 
innovations; more social justice; or improved quality of life.1,2 
 
Within public health and disability research, the ethical inclusion and role of persons with disabilities in 
RCTs has only recently been given attention.6, 19, 20, 21 Generally speaking, ethical conceptions of 
‘disability’ in public health interventions have tended to valorise non-inclusion, for example, in 
institutional ethical review boards or governance structures.22 Most trial-based studies of the general 
population also often apply various forms of exclusion, for example, by discounting participants with 
mental health issues or intellectual disabilities.23 In principle, within RCTs, nobody is excluded per se. 
However, if no culturally and disability sensitive arrangements are made to understand what inclusion 
means for differing minority groups, exclusions are offered, become ethical routines or populations 
are viewed as hard to reach because they do not engage. Asking marginalised groups and in particular, 
those most affected by health inequalities, such as people with intellectual disabilities, if and how they 
want to be involved in public health randomised controlled trials is also a fairly recent 
development.23,25 While research should be inclusive, research is now conceptualising how even in 
recruitment and development of an RCT, people’s experiences should be captured in an ethically 
sensitive and socio-culturally meaningful way. 
 
Amongst socially and politically active people with disabilities,2 there is an understanding of the 
importance of public health and willingness to be involved in intervention research. However, there are 
certain qualifications such as ensuring principles of public and patient involvement (PPI) and 
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inclusion of theories and models of disability to guide research, such as a more social model of human 
rights.1 However, some of the most striking findings of our research were the disillusionment with 
ethics processes and procedures, as well as a lack of trust in not only ethics and human rights but also 
in research to ensure equity.1 In addressing these concerns, we developed a theoretical and practical 
way in which we could combine empirical ethics with human rights to guide and evaluate interventions. 
 
Combining Empirical Ethics with Human Rights 
 
Public health interventions, despite their importance to scientific innovation and influence on national 
and international policy, have been neglected by bioethics. In medical ethics, the ‘empirical- ethical 
turn’26, 27 is well known for combining social science empirical research with normative ethics. Yet, 
according to Salloch et al.28 empirical-ethical research seems to slot mainly into two different 
categories, those that offer conceptual accounts and those that use social science empirical methods to 
understand ethical issues in differing social contexts. We wanted to try and find a third way that was 
more practically orientated in developing an evaluative tool based on empirical ethics. This would aid 
researchers to evaluate ethical decision-making, thus uncovering how research as a social practice 
involving ethics is constructed. We decided to focus on conceptual accounts of how moral decisions 
have been made within research design, but also in terms of social impact on inequalities after research 
has occurred. We wanted a way in which we could evaluate the ‘trustworthiness’29 of an intervention 
which would allow us to develop an empirical ethical tool or guide that would explicitly link ethics to 
better empirical design but also allow innovation.30 
 
Ethical and empirical design could thereby become mutually reinforcing, whereby ethical design leads 
to empirically robust public health research that addresses disabling health inequalities. A way in which 
we thought we could do this would be to link empirical-ethical design to international human rights 
conventions. Historically human rights were not always aligned to disability rights, but influenced by 
Feldman et al.,25 we used the United Nations Convention on the Rights of Persons with Disabilities 
(CRPD)31 to develop an ethical tool that could help to make public health research more inclusive of 
disability, and we argue, thus empirically stronger too. The CRPD is an international human rights treaty 
and innovative legal instrument that also enshrines protected characteristics, such as gender, but 
assigns disabled people ‘rights’ which governments and public bodies have duties to uphold.31 In 
particular, we felt that Article 3 was inclusive of ethical principles relevant to public health research and 
committed to the duty of equality, while also emphasising life-course, sexuality, intersectionality and 
gender. Article 3 of the CRPD specifically notes the following: 
 
“(a) Respect for inherent dignity, individual autonomy including the freedom to make one’s own 
choices, and independence of persons; (b) Non-discrimination; (c) Full and effective participation and 
inclusion in society; (d) Respect for difference and acceptance of persons with disabilities as part of 
human diversity and humanity; (e) Equality of opportunity; (f) Accessibility; (g) Equality between men 
and women; and (h) Respect for the evolving capacities of children with disabilities and respect for the 
right of children with disabilities to preserve their identities”31 
 
There are methodological issues with implementation of rights-based approaches without 
conceptualising how rights link to the empirical robustness of RCT design. One way of ensuring 
empirical robustness but enforcing ethical design would be to link human rights frameworks to those 
guidelines linked to RCT evaluations such as CONSORT,32 PRECIS,33 or RE-AIM.34  For example, we found 
that we could practically link five general principles of Article 3 of the CRPD (intersectionality, inclusion, 
accessibility, dignity and equity) to RE-AIM which evaluates five dimensions of a public health 
interventions (reach, efficacy, adoption, implementation, and maintenance) for empirical 
robustness.1,34  We illustrate this below. 
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Figure 1: IDEAS for RE-AIM 
“The Reach of an intervention or its representativeness is linked to Intersectionality and the kinds of 
population groups that are typically recruited or neglected in research despite experiencing health 
inequalities linked to disability; such as women, children, LGTBQ+ people and people from ethnic 
minority backgrounds or lower-socioeconomic groups. These populations are typically (and 
stereotypically) framed as ‘vulnerable’ or ‘hard to reach’. Intersectionality should also connect with 
the diverse nature of the disabling experience and a range of different impairments. 
 
The Effectiveness of an intervention is linked to primary and secondary outcome measures and how 
they impact on who becomes included (or excluded). It also explains and describes how participation 
in research is viewed and measured. Inclusion is important in ensuring the diversity of the disabling 
experience is captured, which in turn impacts on the use of primary and secondary outcome 
measures. It also raises questions about how inclusion is defined, negotiated, and measured; and the 
extent to which participation is an important consideration. 
 
The Adoption of the intervention is linked to the setting of the intervention and how well the setting 
can be accessed. If a design is universal and accessible, it is more likely to be adopted. In this way, 
Accessibility is linked to mainstream adoption and uptake. 
 
The Implementation of an intervention or how it is adapted to a particular setting, while generally 
linked to cost-effectiveness, can also become linked to the dignity of participants. This includes 
participatory design methods, ensuring ethics and consent and ensuring enabling environment. 
Implementation, therefore, should not be (dis)ableist and modifications need to take account of the 
potential consequences of disability. 
 
The Maintenance of an intervention or its uptake and adaption to real-world settings is linked to 
issues of equity. Equity would address the extent the intervention addresses the social gap, gradient 
or disadvantage linked to disability.”1 
 
 
We then adapted the framework to a simple and accessible guide that researchers as well as people 
with disabilities could use. 
 
Using IDEAS to guide, evaluate and innovate. 
 
We developed a simplified version of RE-AIM34 incorporating the CRPD31 which could be adapted by 
researchers to quantify ethical scores or develop a critical appraisal tool. The enshrinement of the 
CRPD31 in research can in this way, deliver a capacity-building tool by functioning as a link between 
public health and socially informed understandings of disability. Ensuring the tool also functions as 
an evaluative guide means that it becomes adaptable to the needs of both interventions to be 
empirically robust but also stakeholders in assurances of ethical inclusion and social justice. We 
called the tool IDEAS. See Figure 2. 
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Figure 2: IDEAS 
 
RCT Inclusion Dignity Equity Accessibility Equity Inter-Sectionality 
 How were 
people 
included? 
How was 
dignity 
ensured? 
What kind of 
short or long 
term impact 
will this have 
in changing 
inequalities? 
Was 
accessibility 
thought 
about? 
What kind of 
short or long 
term impact 
will this have 
in changing 
inequalities? 
Did they involve 
people with 
different types of 
impairments, 
sexualities, from 
different ethnic 
groups, women or 
children? 
 
The IDEAS guide provides a critical appraisal tool for dealing with the complex ethical and empirical 
issues that arise when designing and/or evaluating public health interventions. The CRPD establishes 
the importance of inclusion, in addition to the need to respect dignity, assurances of 
intersectionality, access and equity when engaging with disability. There are also important legal 
considerations which should not be overlooked in study designs, which an engagement with human 
rights can ensure. For example, assurances of inclusion or dignity in the UK could require an 
engagement with The Mental Capacity Act (2005) which outlines issues like supported decision- 
making. 
 
The use of the CRPD thus also entails that IDEAS is an international framework and can be adopted 
globally.13,14 We illustrate how this could be adapted to the development of all RCTs.35 For example, 
in Figure 3, an illustration is given how IDEAS could be integrated into the Medical Research Council 
guidance for complex interventions.36 
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Figure 3: IDEAS for MRC guidance 
 
 
  
 
  
 
  
 
 
 
 
In the above, IDEAS is integrated in all stages of RCTs from development, piloting and evaluation 
through to assessing implementation. The MRC guidance (similar to RE-AIM) ensures methodological 
robustness while IDEAS ethically refines empirical design for greater inclusion and assurances of 
rights. The potential for using IDEAS in national and international research and developing it further 
to develop indicators of equity, social determinants of human flourishing or adherence of disability 
related projects to human rights exists. The tool also illustrates how innovative empirical ethics can 
be in practice when pragmatically combined with human rights. 
 
Conclusion 
 
Our research suggested that there has been little debate in public health about what ethical 
inclusion in research looks like or how it should be respectful of disability.1 We also noted how 
people with disabilities now felt that they had a right and social need to be involved and co-creating 
research.2 Building on these insights, we illustrated one way in which human rights-based models 
could inform an empirical-ethical critical appraisal tool or evaluative guide. We argue that such 
guides that could be used to critically engage with current empirical evidence, while also allow 
researchers to adapt to more inclusive ethical practices that are sensitive to the experiences of 
disability and expectations of stakeholders. 
 
 
Development 
Rethinking the evidence base. 
Ensuring a link to theory 
Modelling process and outcomes link to 
disability equity. 
 
Evaluation 
Assessing ethics and effectiveness. 
Understanding equity and change as social 
entitlement. 
Assessing short and long term cost-effectiveness 
and uptake. 
 
Implementation 
Accessible dissemination 
Disability surveillance, indicators and monitoring . 
Short and long term follow-up. 
Feasibility /Piloting 
Ensuring IDEAS is  implemented. 
Estimating participation, recruitment and 
retention. 
Sample size and representativeness. 
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